TY  - JOUR
AU  - Perez-de-Llano, Luis A
AU  - Cosio, Borja G
AU  - Domingo, Christian
AU  - Urrutia, Isabel
AU  - Bobolea, Irina
AU  - Valero, Antonio
AU  - Entrenas-Costa, Luis M
AU  - Quirce, Santiago
AU  - Barranco, Pilar
AU  - Marina-Malanda, Nuria
AU  - Prieto-Andres, Luis 
AU  - Alvarez-Gutierrez, Francisco J
PY  - 2019
DO  - 10.1016/j.jaip.2019.01.017
UR  - http://hdl.handle.net/10668/13454
T2  - The journal of allergy and clinical immunology. In practice
AB  - Patients with severe allergic and eosinophilic asthma could qualify for different biologic therapies. To evaluate the efficacy and safety of weight-based intravenous reslizumab dosing in patients who have previously failed therapy with omalizumab. We...
LA  - en
PB  - Elsevier
KW  - Asthma
KW  - Asthma management
KW  - Omalizumab
KW  - Reslizumab
KW  - Severe asthma
KW  - Adult
KW  - Anti-asthmatic agents
KW  - Antibodies, monoclonal, humanized
KW  - Asthma
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle aged
KW  - Omalizumab
KW  - Pilot projects
KW  - Treatment outcome
TI  - Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study.
TY  - research article
VL  - 7
ER  -